The motorcycle maker will take its electric motorcycle division public through a blank-check company.
The drug developer raised its quarterly dividend and added
Investors were disappointed with the biotechnology company's update on a potential cancer treatment.
Bond yields fell and weighed down banks, which rely on higher bond yields to charge more lucrative interest on loans.
Cruise lines and travel-related stocks fell over concerns about the newest coronavirus variant's potential impact on the industry.
The drug developer is collaborating with
The medical technology company completed its buyout of Hillrom.
Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission., source